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Introduction  
Langerhans cell histiocytosis is a rare disorder characterized by proliferation of Langerhans cells. 
It usually presents as a multiple lesions involving multisystem or occasionally as a solitary lesion 
involving a single organ or location. We are presenting a case of Langerhans’cell histiocytosis 
presenting as erythematous, pruritic and ulcerated lesion involving the right labia majora and 
clitoris. It was treated by surgical excision of the lesion by simple vulvectomy. In published 
literature there are only eight reported cases treated by surgery. 
Case Report  
A 41 years old nulliparous, married woman was seen in gynecological outpatient clinics 
complaining of intense pruritis of the vulva and blood stained discharge for the last two years. 
She was of Asian origin and belonged to the lower socioeconomic class.There was no significant 
medical or gynaecological history. General and systemic examination was unremarkable. 
Pelvic examination revealed an ulcerating, blood stained, erythematous lesion involving the 
clitoris and the right labia minora. Vagina, cervix, uterus and the adenexae were normal. No 
lympadenopathy was noted. Pap smear, ultrasound pelvis and the whole abdomen was reported 
to be normal. Vulval biopsy (from several areas) under local anaesthesia was performed with the 
provisional diagnosis of carcinoma of the vulva. The histpathologic evaluation done on 
haematoxylin and eosin stained slide showed skin with stratified squamous epithelium and focal 
ulceration. There was a dense inflammatory infiltrate composed mainly of histiocytes and 
eosinophils mixed with polymorphonuclear neutrophils, lymphocytes and plasma cells extending 
into the deeper dermis. There were also groups of Langerhan cells identified in the deeper 
dermis. There cells showed characteristics Kidney shaped nuclei and nuclear groves. 
Immunohistochemistry performed using DAKO envision method (DAKO CA USA), showed 
reactivity for S-100 and CD-68 in the histiocytic cell population. Histological and 
immunohistochemical findings were characteristic of Langerhan cells histiocytosis. 
Chest radiotherapy, serum biochemistry was normal. Water deprivation test followed by 
vasopressin infusion test; to rule out the co-existence of diabetes insipidis was also performed 
and found to be normal. A diagnosis of “pure” genital Langerhan cell histiocytosis (LCH) was 
made. 
A simple vulvectomy was performed. Post-operative course was unremarkable and she was 
discharged home on the fifth post-operative day. Follow-up six weeks later showed the patient to 
be symptom free. 
Discussion  
Langerhans cell histiocytosis (LCH) affecting the vulva alone, is rare. At present, there are 51 
published cases of LCH affecting the genital area. Of these, only 8 had “pure” Langerhan Cell 
Histiocytosis. In these cases there was no subsequent systemic spread of the disease1. 
Langerhans cell histiocytosis (LCH) is a rare clonal disorder that consists of single or multiple 
mass lesions composed of cells with an abnormal langerhans cell population. Despite extensive 
search for evidence of consistent cytogenetic abnormalities, gene re-arrangements or viral 
genomes, it’s etiology, remains unknown. The biologic behaviour of LCH ranges from 
spontaneous remission to lethal dissemination. Such behaviour cannot be predicted on the basis 
of histologic features. The presence and degree of organ dysfunction, together with the patient’s 
age at diagnosis, remain the most reliable indicators of prognosis2. 
Four distinct patient groups, segregated on the basis of initial presentation and subsequent 
anatomic extent of the disease have been categorized: (a) “Pure” genital LCH (b) Genital LCH 
with subsequent multiorgan involvement: (c) Oral and cutaneous LCH with subsequent genital 
and multiorgan involvement: (d) Diabetes insipidus with subsequent genital and multiorgan 
disease3. 
The treatment of genital LCH is not well defmed and is highly individualized. Therapy has 
included surgery, radiation, topical corticosteroids, topical nitrogen mustard, and systemic 
chemotherapy and combination therapy; mixed results have been obtained with treatment 
modalities. Although no modality has been shown to yield a superior outcome, complete surgical 
excision is advocated as initial therapy4. 
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